BioHeart Files for IPO

BioHeart Inc., a < ?xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags" />Sunrise, Fla.-based developer of heart muscle regeneration therapies, has filed for a $35 million IPO. It plans to trade on the Nasdaq under ticker symbol BHRT, with BMO Capital Markets and Janney Montgomery Scott serving as co-lead underwriters. BioHeart has raised around $40 million in VC funding since 2000, from firms like Ascent Medical Ventures, Guidant Corp., Tyco Capital and Advent-Moro Equity Partners.